CEBP CTRC-AACR San Antonio Breast Cancer Symposium 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaccarella, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaccarella, S.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 2148-2153, November 2006
© 2006 American Association for Cancer Research

Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys

Salvatore Vaccarella1, Rolando Herrero2, Min Dai1, Peter J.F. Snijders3, Chris J.L.M. Meijer3, Jaiye O. Thomas4, Pham Thi Hoang Anh5, Catterina Ferreccio6, Elena Matos7, Hector Posso8, Silvia de Sanjosé9, Hai-Rim Shin10, Sukhon Sukvirach11, Eduardo Lazcano-Ponce12, Guglielmo Ronco13, Raj Rajkumar14, You-Lin Qiao15, Nubia Muñoz8, Silvia Franceschi1 and IARC HPV Prevalence Surveys Study Group

1 International Agency for Research on Cancer, Lyon, France; 2 Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica; 3 VU University Medical Center, Amsterdam, the Netherlands; 4 College of Medicine, University of Ibadan, Ibadan, Nigeria; 5 National Cancer Institute, Hanoi, Vietnam; 6 Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; 7 Instituto de Oncología Angel H. Roffo, Universidad de Buenos Aires, Buenos Aires, Argentina; 8 Instituto Nacional de Cancerología, Bogota, Colombia; 9 Servei d'Epidemiologia i Registre del Cancer Institut Català d'Oncologia, L'Hospitalet del Llobregat, Barcelona, Spain; 10 Research Institute, National Cancer Centre, Goyang, Korea; 11 Research Division, National Cancer Institute, Bangkok, Thailand; 12 Instituto Nacional de Salud Pública, Cuernavaca, Morelos, Mexico; 13 Unit of Cancer Epidemiology, CPO Piemonte, ASO S. Giovanni Battista, Turin, Italy; 14 Christian Fellowship Community Health Centre, Ambilikai, Dindigul District, Tamil Nadu, India; and 15 Cancer Institute/Hospital, Chinese Academy of Medical Sciences, Beijing, China

Requests for reprints: Salvatore Vaccarella, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France. Phone: 33-47273-8097; Fax: 33-47273-8345. E-mail: vaccarella{at}iarc.fr

High parity, early age at first full-term pregnancy (FTP), and long-term oral contraceptive (OC) use increase cervical cancer risk, but it is unclear whether these variables are also associated with increased risk of acquisition and persistence of human papillomavirus (HPV) infection, the main cause of cervical cancer. Information on reproductive and menstrual characteristics and OC use were collected from 14 areas worldwide, among population-based, age-stratified random samples of women aged 15 years or older. HPV testing was done using PCR-based enzyme immunoassay. Unconditional logistic regression was used to estimate the odds ratios (OR) of being HPV-positive according to reproductive and menstrual factors and corresponding 95% confidence intervals (CI). When more than two groups were compared, floating CIs (FCI) were estimated. A total of 15,145 women (mean age, 40.9 years) were analyzed. Women with ≥5 FTPs (OR, 0.90; 95% FCI, 0.76-1.06) showed a similar risk of being HPV-positive compared with women with only one FTP (OR, 1.00; 95% FCI, 0.86-1.16). However, nulliparous women showed an OR of 1.40 (95% CI, 1.16-1.69) compared with parous women. Early age at first FTP was not significantly related to HPV positivity. HPV positivity was similar for women who reported ≥10 years of use of OCs (OR, 1.16; 95% FCI, 0.85-1.58) and never users of OCs (OR, 1.00; 95% FCI, 0.90-1.12). Our study suggests, therefore, that high parity, early age at first FTP, and long-term OC use are not associated with HPV prevalence, but rather these factors might be involved in the transition from HPV infection to neoplastic cervical lesions. (Cancer Epidemiol Biomarkers Prev 2006;15(11):2148–53)




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. Dondog, G. M. Clifford, S. Vaccarella, T. Waterboer, D. Unurjargal, D. Avirmed, S. Enkhtuya, F. Kommoss, N. Wentzensen, P. J.F. Snijders, et al.
Human Papillomavirus Infection in Ulaanbaatar, Mongolia: A Population-Based Study
Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1731 - 1738.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
S. Vaccarella, R. Herrero, P. J F Snijders, M. Dai, J. O Thomas, N. T. Hieu, C. Ferreccio, E. Matos, H. Posso, S. de Sanjose, et al.
Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys
Int. J. Epidemiol., June 1, 2008; 37(3): 536 - 546.
[Abstract] [Full Text] [PDF]


Home page
Int J STD AIDSHome page
K. Syrjanen, I. Shabalova, N. Petrovichev, V. Kozachenko, T. Zakharova, J. Pajanidi, J. Podistov, G. Chemeris, L. Sozaeva, E. Lipova, et al.
Age at menarche is not an independent risk factor for high-risk human papillomavirus infections and cervical intraepithelial neoplasia
Int J STD AIDS, January 1, 2008; 19(1): 16 - 25.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Huang, F. Ye, H. Chen, W. Lu, and X. Xie
Amino acid substitution polymorphisms of the DNA repair gene MGMT and the susceptibility to cervical carcinoma
Carcinogenesis, June 1, 2007; 28(6): 1314 - 1322.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.